News Column

Biotechnology Value Fund L P Files SEC Form SC 13G, Statement of Acquisition of Beneficial Ownership By Individuals (Aug. 15, 2014)

September 6, 2014

By a News Reporter-Staff News Editor at Investment Weekly News -- According to news reporting originating from Washington, D.C., by VerticalNews journalists, a U.S. Securities and Exchange Commission (SEC) filing by Biotechnology Value Fund L P (Form SC 13G) was posted on August 15, 2014.

The SIC code for this company is 6282, Investment Advice.

There were 2 documents filed with this form. The SEC file number is 0000921895-14-001896.

The contact information for this company is ONE SANSOME ST, 30TH FL, SAN FRANCISCO CA 94104, 3125066500.

Our editors provided additional information about Form SC 13G: Schedule 13G is a much abbreviated version of Schedule 13D that is only available for use by a limited category of "persons" (such as banks, broker/dealers, and insurance companies) and even then only when the securities were acquired in the ordinary course of business and not with the purpose or effect of changing or influencing the control of the issuer.

A U.S. Securities and Exchange Commission filing is a formal document or financial statement submitted to the SEC by publicly-traded companies.

For additional information on this SEC filing see:

Keywords for this news article include: SEC Filing, Investment Advice, Biotechnology Value Fund L P.

Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2014, NewsRx LLC

For more stories on investments and markets, please see HispanicBusiness' Finance Channel

Source: Investment Weekly News

Story Tools Facebook Linkedin Twitter RSS Feed Email Alerts & Newsletters